Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...

The move comes weeks after Pfizer terminated its partnership with Sangamo Therapeutics for another hemophilia gene therapy.

Pfizer has announced that it has entered into a marketing and supply agreement with Mylan Pharmaceuticals for the marketing and sale of two of its brands, Ativan and Pacitane.

Mylan, which has an established presence in the central nervous system therapy segment, is expected to leverage its network ...

There are plenty of great investment alternatives in the healthcare sector. You won't need a boatload of money to get started, either. Here are two no-brainer healthcare stocks to buy with $500 right ...

New Delhi: Pfizer Ltd on Friday said its board has approved signing a marketing and supply agreement with Mylan ...

The CEO of Pfizer received loud boos when he was introduced by Donald Trump at a Black History Month event at the White House ...

President Donald Trump's introduction of a Pfizer executive at the White House Wednesday was met with a roar of boos from the crowd.

An intriguing battle is brewing in the market to treat patients with transthyretin amyloid cardiomyopathy (ATTR-CM). | BridgeBio reported that 1,028 unique prescriptions have been written by 516 ...

The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of ...

US president Donald Trump has only been back in office for just over a month, but he is already engaging in trade wars with ...

Recent health news highlights controversial language restrictions within the FDA, legal actions against vape distributors in ...